Marblegate Capital MGTE
OTC MGTE
$1.34 -0.02 (-1.47%)
As of: Aug 19, 2026 · 9:59 AM EDT

Marblegate Capital (MGTE) EBIT (2024 - 2026)

Marblegate Capital's (MGTE) quarterly EBIT came in at -$616000.0 in Q4 2025, down 156.31% YoY from $1.1 million in Q4 2024, and up 50.36% on a QoQ basis from -$1.2 million in Q3 2025.

Marblegate Capital (MGTE) EBIT (2024 - 2026) Analysis & Trends

Marblegate Capital (MGTE) has 2 years of EBIT data on file, last reported at -$616000.0 in Q4 2025.

  • Quarterly EBIT fell 156.31% year-over-year to -$616000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 million (down 61.18% YoY) and the FY2025 annual result came in at $809000.0, down 86.7% from the prior year.
  • EBIT improved to -$616000.0 in Q4 2025, from -$1.2 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $3.6 million in Q2 2025 to a low of -$1.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Launch Two Acquisition 557.86 Mn 557.86 Mn - -194,528.00
2 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - -112,227.00
3 Cantor Equity Partners IV 467.55 Mn 467.55 Mn - -174,182.00
4 GP-Act III Acquisition 401.06 Mn 401.06 Mn - -1.47 Mn
5 Aldel Financial 397.49 Mn 397.49 Mn - -115,742.00
6 Gores Holdings X 381.05 Mn 380.85 Mn - -1.35 Mn
7 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - -
8 Blue Water Acquisition Corp. III 342.12 Mn 342.08 Mn - -197,949.00
9 Berto Acquisition 313.96 Mn 313.81 Mn - -1.62 Mn
10 Marblegate Capital 87.22 Mn 180.32 Mn - -4.30 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.30 Mn
Dec 31, 2025 -616,000.00
Sep 30, 2025 -1.24 Mn
Jun 30, 2025 3.56 Mn
Mar 31, 2025 -91,619.00
Dec 31, 2024 1.09 Mn
Sep 30, 2024 1.85 Mn
Jun 30, 2024 1.20 Mn